Biotech

All Articles

OS Treatments refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies will note on the NYSE American supply swap today through a $6.4 million ...

ALX's waning CD47 reaction cost delivers sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells feedback cost has diminished. After observing its CD47 ...

Ionis centers eye illness from targets of Roche-partnered prospect after data dissatisfy

.Another of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of assumpti...

Biogen's chief executive officer mentioned no risky handle 2023. He's ready to be daring

.While Biogen's pharma peers are searching for late-stage possessions along with little danger, chie...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has been actually a biotech looking for a pipe after it ditched its own lead resou...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned civil rights to a very early Alzheimer's condition program to Denali R...

Takeda water faucets brand new head people oncology company-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings ...

Vertex, beaten through AATD once more, drops 2 assets on dispose of stack

.Tip's try to alleviate a rare genetic health condition has actually struck an additional obstacle. ...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter earnings file wasn't except big updates. The business welcomed a...

Galapagos stops CAR-T tissue therapy trial over Parkinsonism situation

.Galapagos has stopped registration in a trial of a BCMA-directed CAR-T cell treatment, pushing the ...